John J. Monahan
Director · Theriva Biologics, Inc.
Individual
- 2025
- Apr 29, 2025
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at John J. Monahan's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Robert M. Williams Jr. - $371.84M in AVAH purchases and sales in the last 12 months
- Fairmount Funds Management LLC - $370.02M in COGT purchases and sales in the last 12 months
- August J. Troendle - $358.45M in MEDP purchases and sales in the last 12 months
- J.H. Whitney Equity Partners VII, LLC - $319.15M in AVAH purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $317.75M in CELC purchases and sales in the last 12 months
- A/S Genmab - $234.86M in MRUS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John J. Monahan?
John J. Monahan is a corporate insider, tracked as Director of Theriva Biologics, Inc. (TOVX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did John J. Monahan last file a Form 4?
The only primary Form 4 on record is dated 29 April 2025.